Tacrolimus, Kaposiform Hemangioendothelioma, Tufted Angioma Clinical Trial
Official title:
Tacrolimus for the Treatment of Superficial Kaposiform Hemangioendothelioma and Tufted Angiomaļ¼a Randomized Controlled Study
The aim of this study was to evaluate the efficacy and safety of topical application of tacrolimus at different concentrations for superficial Kaposiform hemangioendothelioma (KHE) and tufted angioma (TA).
Kaposiform hemangioendothelioma (KHE) and tufted angiomas (TA) are rare vascular tumors, which are apparent predominantly in infancy or early childhood. Currently, no standard treatment regimens exist for KHE/TA. The aim of this study was to evaluate the efficacy and safety of topical application of tacrolimus at different concentrations for superficial Kaposiform hemangioendothelioma (KHE) and tufted angioma (TA). ;